Browse Zenopa News Archive
 search our vacancies database
Browse by Category:
Animal Health Supplier News | Animal Health/ Animal Health surgeon news | Company financials | Company product news | Company restructures | Dental / Dental Practitioner News | Dental Supplier News | Director Appointments and Resignations | Government/NHS related news | Industry related health news | Interview with the MD | Key Industry Interview | Marketing Services | Medical - company restructures | Medical Company Financials | Medical Company Product News | Medical Company Restructures | Medical Government/ NHS related news | None | Pharmaceutical Company Financials | Pharmaceutical Company Product News | Pharmaceutical Company Restructures | Pharmaceutical Government/ NHS related news | Pharmacy / Pharmacist News | Pharmacy Supplier News | Scientific | Vet / Veterinary Surgeon News | Veterinary Supplier News | All Categories
Browse by Month:
Apr 2010 | Mar 2010 | Feb 2010 | 2009 | Dec 2009 | Nov 2009 | Oct 2009 | Sep 2009 | Aug 2009 | Jul 2009 | Jun 2009 | May 2009 | Apr 2009 | Mar 2009 | Feb 2009 | 2008 | Dec 2008 | Nov 2008 | Oct 2008 | Sep 2008 | Aug 2008 | Jul 2008 | Jun 2008 | May 2008 | Apr 2008 | Mar 2008 | Feb 2008 | 2007 | Dec 2007 | Nov 2007 | Oct 2007 | Sep 2007 | Aug 2007 | Jul 2007 | Jun 2007 | May 2007 | Apr 2007 | Mar 2007 | Feb 2007 | 2006 | Dec 2006 | Nov 2006 | Oct 2006 | Sep 2006 | Aug 2006 | Jul 2006 | Jun 2006 | May 2006 | Apr 2006 | Mar 2006 | Feb 2006 | 2005 | Dec 2005 | Feb 2001 | Feb 2000 | All Dates Here are the most recent stories: Bausch and Lomb appoints vision care executive
Posted on 11/03/2010 in Pharmacy Supplier News Bausch and Lomb has selected Dr Robert Steffen as its new director of clinical affairs for its vision care unit. Read MoreAstraTech unveils new OsseoSpeed TX implant
Posted on 11/03/2010 in Dental Supplier News AstraTech has launched the latest evolution of its OsseoSpeed TX dental implant range at an industry conference. Read MoreSartorius reports earnings increase in 2010
Posted on 11/03/2010 in Scientific Sartorius has published its financial results for 2009, during which it was able to increase its earnings despite a difficult economic climate. Read MoreLife Technologies system used in groundbreaking research
Posted on 11/03/2010 in Scientific Life Technologies has revealed that its Applied Biosystems SOLiD System has been utilised in potentially groundbreaking research into Charcot-Marie-Tooth disease. Read MoreDoctors express concerns over patient records
Posted on 11/03/2010 in Medical Government/ NHS related news The British Medical Association (BMA) has expressed concern that patient details are being uploaded too quickly onto a NHS national IT database. Read MoreAdvanced Medical Solutions reports rising revenues in 2009
Posted on 11/03/2010 in Medical Company Financials Advanced Medical Solutions has hailed its strong financial performance in 2009 after experiencing a 19 per cent increase in revenues. Read MoreAbbott receives FDA approval for intraocular lens
Posted on 11/03/2010 in Medical Company Product News Abbott has been granted Food and Drug Administration approval for a new intraocular lens (IOL) designed for cataract sufferers. Read MorePorter Novelli appoints EMEA healthcare regional head
Posted on 11/03/2010 in Marketing Services Porter Novelli has appointed Shipra Singh to the newly-created role of head of its EMEA healthcare operations. Read MoreBayer Schering Pharma granted orphan drug status for CF treatment
Posted on 11/03/2010 in Pharmaceutical Company Product News Bayer Schering Pharma has received orphan drug designation from the Food and Drug Administration (FDA) for a treatment for chronic pulmonary infections related to cystic fibrosis (CF). Read MoreAstraZeneca agrees deal with Torrent over generics portfolio
Posted on 11/03/2010 in Pharmaceutical Company Product News AstraZeneca has purchased licensing and marketing rights to a number of generic medicines from Indian healthcare firm Torrent Pharmaceuticals. Read MoreTakeda makes milestone payment to Affymax over Hematide development
Posted on 11/03/2010 in Pharmaceutical Company Product News Takeda has paid $5 million (3.3 million pounds) to its collaborative partner Affymax after achieving an important milestone in the development of the drug Hematide. Read MoreAllergan receives approval for Botox in muscle stiffness treatment
Posted on 11/03/2010 in Pharmaceutical Company Product News Allergan has received approval from the Food and Drug Administration for its Botox drug to be used as a treatment for muscle stiffness. Read MoreDr Foster Intelligence co-founder to leave company
Posted on 10/03/2010 in Marketing Services Dr Foster Intelligence has announced that its co-founder Tim Kelsey is to depart the company for a new role at McKinsey and Company. Read MoreMerial to merge with Intervet/Schering-Plough
Posted on 10/03/2010 in Animal Health Supplier News Merial is to be combined with fellow animal health company Intervet/Schering-Plough in a move which will create one of the world's largest veterinary pharmaceuticals firms. Read MoreTeva appoints new chairman of board of directors
Posted on 10/03/2010 in Pharmacy Supplier News Teva has selected Dr Phillip Frost as the new permanent chairman of its board of directors.Dr Frost, who previously served as the board's vice-chairman. Read MoreHoriba launches SPRi-Plex II for biomolecular analysis
Posted on 10/03/2010 in Scientific Horiba Scientific has launched a new version of its SPRi-Plex biomolecule analysis system, which is designed to be faster and more versatile than its predecessor. Read MoreAgilent to divest Varian product lines to Bruker
Posted on 10/03/2010 in Scientific Agilent Technologies is to divest a number of product lines from its newly-acquired subsidiary Varian to the scientific instruments company Bruker. Read MoreWomen who drink moderately 'gain less weight than non-drinkers'
Posted on 10/03/2010 in Medical Government/ NHS related news A study has found that women who drink a moderate amount of alcohol appear to gain less weight than non-drinkers. Read MoreOrthofix agrees sale of vascular business assets to Covidien
Posted on 10/03/2010 in Medical Company Restructures Orthofix International has confirmed a deal to sell its vascular business and associated assets to fellow medical technology company Covidien. Read MoreArk Therapeutics 'committed to future business growth'
Posted on 10/03/2010 in Medical Company Product News Ark Therapeutics has stated that it will be looking to continue building on its corporate strengths despite recent setbacks with its Cerepro brain cancer drug. Read More
| 
